Chargement en cours…
Protein kinase inhibitors as sensitizing agents for chemotherapy /
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer...
| Cote: | Libro Electrónico |
|---|---|
| Autres auteurs: | , |
| Format: | Électronique eBook |
| Langue: | Inglés |
| Publié: |
London, United Kingdom :
Academic Press, an imprint of Elsevier,
[2019]
|
| Collection: | Cancer sensitizing agents for chemotherapy ;
v. 4. |
| Sujets: | |
| Accès en ligne: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1076269079 | ||
| 003 | OCoLC | ||
| 005 | 20231120010329.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 181126s2019 enk ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d UKMGB |d YDX |d OPELS |d OCLCF |d CASUM |d S2H |d OCLCO |d LVT |d VT2 |d OCLCA |d OCLCQ |d OCLCO |d K6U |d OCLCQ |d OCLCO | ||
| 015 | |a GBB8M4573 |2 bnb | ||
| 016 | 7 | |a 019140095 |2 Uk | |
| 019 | |a 1076467864 |a 1141465107 |a 1229466097 |a 1235826195 | ||
| 020 | |a 9780128127384 |q (electronic bk.) | ||
| 020 | |a 0128127384 |q (electronic bk.) | ||
| 020 | |a 9780128164358 |q (electronic bk.) | ||
| 020 | |a 0128164352 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1076269079 |z (OCoLC)1076467864 |z (OCoLC)1141465107 |z (OCoLC)1229466097 |z (OCoLC)1235826195 | ||
| 050 | 4 | |a RC271.P76 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.994061 |2 23 |
| 245 | 0 | 0 | |a Protein kinase inhibitors as sensitizing agents for chemotherapy / |c Zhe-Sheng Chen and Dong-Hua Yang, editors. |
| 264 | 1 | |a London, United Kingdom : |b Academic Press, an imprint of Elsevier, |c [2019] | |
| 264 | 4 | |c �2019 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Cancer sensitizing agents for chemotherapy ; |v volume 4 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed November 27, 2018). | |
| 520 | |a Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials. | ||
| 650 | 0 | |a Protein-tyrosine kinase |x Inhibitors |x Therapeutic use. | |
| 650 | 0 | |a Cancer |x Chemotherapy. | |
| 650 | 0 | |a Protein kinases |x Therapeutic use. | |
| 650 | 1 | 2 | |a Protein Kinases |x therapeutic use |0 (DNLM)D011494Q000627 |
| 650 | 6 | |a Prot�eine-tyrosine kinase |0 (CaQQLa)201-0372706 |x Inhibiteurs |0 (CaQQLa)201-0372706 |x Emploi en th�erapeutique. |0 (CaQQLa)201-0373975 | |
| 650 | 6 | |a Cancer |x Chimioth�erapie. |0 (CaQQLa)201-0004691 | |
| 650 | 6 | |a Prot�eines kinases |0 (CaQQLa)201-0081630 |x Emploi en th�erapeutique. |0 (CaQQLa)201-0373975 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Cancer |x Chemotherapy |2 fast |0 (OCoLC)fst00845327 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Chen, Zhe-Sheng (Jason), |e editor. | |
| 700 | 1 | |a Yang, Dong-Hua, |e editor. | |
| 776 | 0 | 8 | |i Print version: |z 0128164352 |z 9780128164358 |w (OCoLC)1037806447 |
| 830 | 0 | |a Cancer sensitizing agents for chemotherapy ; |v v. 4. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128164358 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/book/9780128164358 |z Texto completo |